Annual Operating Expenses
$192.40 M
+$107.75 M+127.27%
December 31, 2024
Summary
- As of March 12, 2025, MLYS annual total operating expenses is $192.40 million, with the most recent change of +$107.75 million (+127.27%) on December 31, 2024.
- During the last 3 years, MLYS annual operating expenses has risen by +$173.68 million (+927.52%).
- MLYS annual operating expenses is now at all-time high.
Performance
MLYS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$51.77 M
-$8.34 M-13.87%
December 31, 2024
Summary
- As of March 12, 2025, MLYS quarterly total operating expenses is $51.77 million, with the most recent change of -$8.34 million (-13.87%) on December 31, 2024.
- Over the past year, MLYS quarterly operating expenses has increased by +$24.06 million (+86.81%).
- MLYS quarterly operating expenses is now -13.87% below its all-time high of $60.11 million, reached on September 30, 2024.
Performance
MLYS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
MLYS Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +127.3% | +86.8% |
| 3 y3 years | +927.5% | +86.8% |
| 5 y5 years | +6437.6% | +86.8% |
MLYS Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +927.5% | -13.9% | +699.0% |
| 5 y | 5-year | at high | +6437.6% | -13.9% | +699.0% |
| alltime | all time | at high | +6437.6% | -13.9% | +699.0% |
Mineralys Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $192.40 M(+127.3%) | $51.77 M(-13.9%) |
| Sep 2024 | - | $60.11 M(+33.1%) |
| Jun 2024 | - | $45.17 M(+27.7%) |
| Mar 2024 | - | $35.36 M(+27.6%) |
| Dec 2023 | $84.66 M | $27.71 M(+5.5%) |
| Sep 2023 | - | $26.27 M(+67.0%) |
| Jun 2023 | - | $15.73 M(+5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $14.94 M(+49.3%) |
| Dec 2022 | $31.48 M(+68.1%) | $10.01 M(+34.8%) |
| Sep 2022 | - | $7.42 M(+14.6%) |
| Jun 2022 | - | $6.48 M(-14.4%) |
| Mar 2022 | - | $7.57 M(+6.9%) |
| Dec 2021 | $18.73 M(+536.3%) | - |
| Dec 2021 | - | $7.08 M |
| Dec 2020 | $2.94 M | - |
FAQ
- What is Mineralys Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual operating expenses year-on-year change?
- What is Mineralys Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly operating expenses year-on-year change?
What is Mineralys Therapeutics annual total operating expenses?
The current annual operating expenses of MLYS is $192.40 M
What is the all time high annual operating expenses for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual total operating expenses is $192.40 M
What is Mineralys Therapeutics annual operating expenses year-on-year change?
Over the past year, MLYS annual total operating expenses has changed by +$107.75 M (+127.27%)
What is Mineralys Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of MLYS is $51.77 M
What is the all time high quarterly operating expenses for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly total operating expenses is $60.11 M
What is Mineralys Therapeutics quarterly operating expenses year-on-year change?
Over the past year, MLYS quarterly total operating expenses has changed by +$24.06 M (+86.81%)